Back to results
US 2024/0189411 A1Published application
Monovalent vaccine formulation and a method for preparation thereof
AssigneeAimst University
InventorsGuruswamy PRABHAKARAN, Manickam RAVICHANDRAN, Kurunathan A/L SINNIAH, Yean Yean CHAN
Life of this patent
Estimating the term…
Abstract
The present invention discloses a vaccine formulation in accordance with an illustrative embodiment. The formulation including a live attenuated cholera vaccine strain VCUSM14P; a vaccine medium having starch, cellulose, dextrose, and yeast extract; and a phosphate buffer saline.
Claims4
A method for storage of a monovalent vaccine formulation against Vibrio cholerae 0139 comprising a live attenuated cholera vaccine strain;
- a vaccine medium having starch, cellulose, dextrose, and yeast extract;
- and
- a phosphate buffer saline;
- wherein the strain is VCUSM14P;
- and wherein the vaccine medium comprising starch (3.25-6.75%), cellulose (2.50-4%), dextrose (18.25-24.50%), yeast extract (0.01-0.05%), and NaCl (0.05-0.15%)
- comprising the step of maintaining said monovalent vaccine formulation storage stability at 25° C.±2° C. in a cold chain-free system for 180 days and maintaining at 60%±5% humidity for a period of 180 days.
3 more elements
Dependencies are inferred from the claim text.